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Background/aim: To investigate possible protective effects of Ankaferd Blood Stopper® (ABS) in an experimental liver ischemia
reperfusion injury (IRI) model.
Materials and methods: The study was carried out on 30 female rats separated into 3 groups as sham, control (IRI), and treatment (IRI +
ABS) groups. In the IRI + ABS group, 0.5 mL/day ABS was given for 7 days before surgery. In the IRI and IRI + ABS groups, the hepatic
pedicle was clamped for 30 min to apply ischemia. Then, after opening the clamp, 90-min reperfusion of the liver was provided. Blood
and liver tissue samples were taken for biochemical and histopathological analyses.
Results: Compared to the sham group, the IRI group had significantly higher levels of alanine aminotransferase (ALT), aspartate
aminotransferase (AST), total oxidant status (TOS), malondialdehyde (MDA), fluorescent oxidant products (FOP) and lower expression
of albumin and total antioxidant status (TAS) (P < 0.05). Compared to the IRI group, the IRI+ABS group showed lower expression of
AST, ALT, TOS, MDA and FOP and higher expression of albumin and TAS (P < 0.05). In the histopathological analysis, congestion
scores were statistically significantly lower in the IRI + ABS group than in the IRI group.
Conclusions: ABS has a strong hepatoprotective effect due to its antioxidant and antiinflammatory effects and could therefore be used
as a potential therapeutic agent for IRI.
Key words: Ischemia reperfusion injury, Ankaferd Blood Stopper, liver

1. Introduction
Ischemia reperfusion injury (IRI) is a critical condition
which presents serious therapeutic challenges for
clinicians. It occurs due to the restoration of blood supply
following prolonged ischemia. During the ischemic
period, anaerobic metabolism and dysfunction of the
electron transport chain in mitochondria are promoted.
Cell swelling and disrupted enzyme activity in the
cytoplasm occurs as a result of decreased adenosine
triphosphate (ATP) production because of dysfunction of
the ion exchange channels. After blood flow restoration
(reperfusion), oxidative stress, reactive oxygen species,
and local inflammation leading to secondary injury are

induced by electrolyte imbalance and mitochondrial
damage. Finally, the retention of reactive oxygen species
leads to cell death by means of autophagy, mitoptosis,
necrosis, necroptosis, and apoptosis [1–4].
IRI can affect multiple organs including the liver,
heart, intestine, kidneys, and brain and is also related
to grave clinical manifestations such as systemic
inflammatory response syndrome, acute heart failure,
myocardial hibernation, cerebral dysfunction, multiple
organ dysfunction syndrome, and liver dysfunction. In
hepatic IRI pathogenesis, several factors and pathways
play a role, such as mitochondria, anaerobic metabolism,
intracellular calcium overload, oxidative stress, cytokines
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and chemokines, and liver Kupffer cells and neutrophils
[5]. It is possible for hepatic IRI to cause serious liver
dysfunction. It may even inflict irreversible damage in
the body, which then results in a series of multiple organ
dysfunction [5,6]. Hepatic IRI occurs during different
surgical interventions implemented for intrahepatic
lesions or liver transplantation. These surgical procedures
need a certain period of ischemia to allow total vascular
exclusion or Pringle’s manoeuvre (inflow control) [7].
Although several studies have investigated nitric oxide,
hesperidin, diosmin, infliximab, calcium dobesilate and
glycyrrhetinic acid, to prevent or decrease hepatic IRI,
there is still no agent commonly used in clinical practice
[5, 8–10].
Ankaferd Blood Stopper® (ABS) is a most well known
topical hemostatic agent and contains standardized plant
extracts taken from Glycyrrhiza glabra, Urtica dioica,
Vitis vinifera, Thymus vulgaris, and Alpinia officinarum
[11]. The herbs listed here have effects on blood cells,
endothelium, the proliferation of cells, angiogenesis, and
vascular dynamics, and vascular mediators. Moreover,
some also have antioxidant and antiinflammatory effects
[12,13], which may be useful for hepatic IRI. Only a limited
number of studies have been carried out to investigate how
ABS affects liver surgery and hepatic IRI. The aim of this
study was to investigate the possible protective effects of
ABS in an experimental liver IRI model.
2. Materials and methods
Approval for the study was granted by the Animal Ethics
Committee. The experimental procedures and technique of
this study met the requirements of the national guidelines
for the use and care of laboratory animals.
2.1. Animals and experimental surgical procedure
The study sample consisted of 30 female adults Wistar
albino rats, each with a weight of 230 ± 22 gr. The rats
were housed in cages made of wire netting at a permanent
temperature of 21 ± 2 °C with a 12-h light/dark cycle. The
animals had a diet consisting of standard laboratory supply
chow and water ad libitum. Access to food was stopped 12 h
before anesthesia and to water 2 h prior to anesthesia for the
rats. The same team conducted the anesthesia and surgical
intervention stages under sterile conditions. Before the
intervention procedures, anaesthesia was administered of
50 mg/kg ketamine hydrochloride (Ketalar; Parke-Davis,
Detroit, MI, USA) and 5mg/kg Xylazine (Rompun; Bayer
AG, Leverkusen, Germany) via intramuscular injection.
The rats were randomly assigned to 3 groups of 10
rats: the sham group, the control group, and the treatment
group.
In Group 1 (sham), only hepatic pedicle was induced.
In Group 2 (control) (IRI), ischemia was performed
by clamping the hepatic pedicle for 30 min. Following the
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ischemia application, the clamp was opened and 90-min
reperfusion of the liver was performed.
In Group 3 (treatment) (IRI + ABS), 0.5 mL/day ABS
was administered via an orogastric tube for 7 days before
the surgery. Ischemia was applied by clamping the hepatic
pedicle for 30 min, then the clamp was opened to provide
reperfusion for 90 min.
After the completion of these procedures, all the
rats were euthanized with ketamine overdose. After
the laparotomy, blood samples were taken from the
aorta and tissue samples were obtained from liver for
histopathological and biochemical analysis.
2.2. Histopathological analysis
The rat liver tissue samples were fixed in a solution
containing 10% formaldehyde for a period of 24 h
and then embedded in blocks of paraffin. From these,
sections 4 µm in thickness were cut with a microtome
(Leica RM 2155 RT, Leica Microsystems GmbH, Wetzlar,
Germany). Hematoxylin and eosin were used to stain
these tissue sections and then the stained sections were
analyzed. The samples were examined histopathologically
using an Olympus BX51TF light microscope (Olympus
Corporation, Tokyo, Japan) by a pathologist who was
blinded to the groups. In the histopathological evaluation,
the modified Suzuki scoring system [14] from 0 to 4 was
used to grade sinusoidal congestion, liver cell vacuolization
and hepatocyte necrosis. The modified Suzuki scoring
system is shown in Table 1.
2.3. Biochemical analysis
Liver functions in the serum and oxidative stress
parameters were evaluated. The measurement of aspartate
aminotransferase (AST), alanine aminotransferase (ALT),
albumin, total and direct bilirubin was performed using a
Roche Cobas 8000 chemistry analyzer (Roche Diagnostics,
Risch-Rotkreuz, Switzerland).
The liver tissue samples were kept at –80 °C until the
day of the laboratory and histological assessment. Total
oxidant status (TOS), total antioxidant atatus (TAS),
malondialdehyde (MDA) and fluorescent oxidation
products (FOP) levels were determined. The levels of TOS
and TAS were measured by applying the TOS and TAS
kits of Rel Assay Diagnostic to the Roche Cobas 6000
instrument.
In the measurement of TAS, the antioxidants
in the sample reduce the radical 2,2′-Azino-bis(3ethylbenzothiazoline-6-sulfonic acid) (ABTS), which is
dark blue-green colored to a colorless reduced ABTS form.
Absorbance change at 660 nm is associated with the level
of total antioxidants present in the sample. The calibration
of the assay was carried out using a stable antioxidant
standard solution of Trolox equivalent, an analogue of
vitamin E.
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Table 1. The histopathological scoring system (Suzuki) of the liver samples [14].
Grade

Sinusoidal congestion

Vacuolization

Necrosis

0

None

None

None

1

Mild

Mild

Simple cell necrosis

2

Moderate

Moderate

0%–30 %

3

Severe

Severe

30%–60 %

4

Excessive

Excessive

>60%

In the measurement of TOS, ferrous ion-chelator
complex is oxidized to ferric ion via to oxidants within
the sample. Enhancer molecules, which can be found in
great numbers in the medium of reaction, prolong the
reaction of oxidation. Ferric ion produces a complex
colored with chromogen in an acidic medium. The
intensity of color, which can be spectrophotometrically
measured, is associated with the total quantity of oxidants
present within the sample. Hydrogen peroxide was used to
calibrate the assay. The results of TAS and TOS were stated
as µmol/g protein.
MDA functions as an indicator of lipid peroxidation and
is known to be an index of tissue injury. The fluorometric
method was used to measure MDA levels as described
by Wasowicz et al. [15]. Following the reaction between
thiobarbituric acid (TBA) and MDA, the product of the
reaction was isolated in butanol. Then spectrofluorometric
measurement was taken at a wavelength of 547 nm
for emission and 525 nm for excitation. The standard
was designated as a solution of 0–5 µmol/L 1,1’,3,3’
tetraethoxypropane. In order to measure the MDA levels
in the tissue, 50 µL of homogenate was added into glass
tubes of 10 mL, each of which contained 1 mL of distilled
water. Following this step, a 1-mL solution that contained
29 mmol/L TBA was added to acetic acid and mixed. Then,
the samples were exposed to a temperature of 95–100°C for
1 h using a water bath. After cooling the heated samples,
they were mixed with 25 µL of 5 mol/L hydrochloric acid
(HCL) and agitation was applied for 5 min to extract the
mixture of the reaction using 3.5 mL n-butanol. After the
butanol phase was separated through centrifugation for
10 min at 1500 g, a fluorometer (HITACHI F-2500) was
used to measure the fluorescence in the butanol extract
at 547 nm and 525 nm wavelengths for emission and
excitation, respectively. Solutions of 0–5 µmol/L 1,1’,3,3’
tetraethoxypropane were utilized as the standard. The
levels of MDA were shown as nmol/g protein. Tissues that
were homogenized were isolated by means of ethanol-ether
(3/1, v/v) for the measurements of FOP. Following this, a
spectrofluorometer was used to evaluate these tissues at
wavelengths of 360 and 430 (wavelengths for excitation/
emission) [16].

2.4. Statistical analysis
The data were analyzed statistically with SPSS 23.0 software
(IBM Corp., Armonk, NY, USA). The Shapiro–Wilk’s test,
skewness and kurtosis values were used to analyze the data
distribution. All data were expressed as mean ± standard
deviation (SD). The statistical analysis of the results was
performed using unpaired Student’s t-tests and ANOVA
models (with Tamhane’s post hoc test) with normally
distributed data. For other type of data, the Mann–
Whitney U test and the Kruskal–Wallis tests were used. The
association between categorical variables was tested using
chi-square test or Fisher’s exact test. Significance was
considered when P < 0.05 and supported by Bonferroni
multiple testing correction.
3. Results
3.1. Histopathological findings
The histopathological results of the study are shown in
Table 2. The lowest congestion scores were found in the
sham group and the highest congestion scores in the
IRI group. Congestion scores were determined to be
statistically significantly lower in the IRI + ABS group than
in the IRI group (P = 0.005).
In the histopathological assessment, vacuolization
and necrosis were not seen in the sham group and were
detected more in the IRI group compared to the IRI +
ABS group. There was statistical significance between the
sham and IRI groups in respect of vacuolization (P = 0.03),
and no statistically signiﬁcant difference was observed
between the IRI and IRI+ABS groups (P = 0.15). The
groups displayed no statistical significance in respect of
the necrosis scores (group sham vs. IRI: P = 0.22, IRI vs.
IRI + ABS: P = 0.64) (Figure).
3.2. Biochemical findings- liver function test
Compared to the IRI and IRI+ABS groups, the sham
group had the lowest ALT and AST values and the highest
albumin values. The analysis revealed a difference of
statistical significance (P < 0.05). The IRI+ABS group was
determined to have higher albumin levels and lower AST
and ALT levels than the IRI group (P < 0.05).
There was no statistical significance between the groups
in respect of total bilirubin and direct bilirubin values (P >
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Table 2. The mean histopathological scores of the study groups.
Groups

Congestion
(mean ± SD)

Vacuolisation
(mean ± SD)

Necrosis
(mean ±SD)

Group 1 (sham)

0.60 ± 0.51x

0.00 ± 0.00z

0.00 ± 0.00

Group 2 (IRI)

2.20 ± 0.78

0.80 ± 0.78

0.30 ± 0.28

Group 3 (IRI+ABS)

1.0 ± 0.66 y

0.20 ± 0.42

0.10 ± 0.10

x. y

z

Significantly different. xP < 0.001 for group 1 versus group 2,
y
P =0.005 for group 2 versus group 3, zP = 0.03 for group 1 and group 2.
IRI: Ischemia reperfusion injury, ABS: Ankaferd Blood Stopper.

Figure. Histopathological findings are shown in figure. There was not any congestion and vacuolization in sham group (Figure 1a).
While moderate congestion and vacuolization were seen in control group (Figure 1b), mild congestion and vacuolization were seen in
treatment group (Figure 1c).

0.05). The test results of the liver function tests are shown
in detail in Table 3.
3.3. Biochemical findings- oxidative stress parameters
The oxidative stress parameter values are shown in detail
in Table 4.
The values of TOS, FOP, and MDA were the lowest
in the sham group, and the value of TAS was the highest
in the sham group. With the exception of the TOS values
between the sham and IRI + ABS groups (P = 0.231), all
the other values reached statistical significance (P < 0.05).
The IRI + ABS group was found to have lower levels of
TOS, FOP, and MDA, and higher levels of TAS than the
IRI group (P < 0.05).
4. Discussion
The most significant finding of this study was that ABS has
hepatoprotective effects on experimental liver IRI in rats.
According to both the histopathological and biochemical
results of this study, the IRI + ABS group showed better
results than the IRI group in terms of liver function
and tissue samples after IRI was performed. Therefore,
although ABS is known as a hemostatic agent, because
of the antioxidant and anti-inflammatory components it
could be an alternative treatment for hepatic IRI.
Liver IRI is an important scenario which has been
extensively studied in recent decades and remains a
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therapeutic challenge for clinicians. It is related to a
number of clinical situations, such as hemorrhagic shock,
resuscitation, trauma, liver transplantation, and liver
resection. It results from a complicated pathological
network with a combination of factors such as impairment
of sinusoidal endothelial cells, inflammation, disturbance
of microcirculation, activation of Kupffer cells,
accumulation of leukocytes, activation of complement
factors, oxidative stress, apoptosis, and necrosis [17,18].
Various pharmacological agents such as endothelin,
adenosine and nitric oxide agonists, prostaglandins,
antagonists,
complement inhibiters, Kuppfer cell
inactivators, neutrophil inactivators, antioxidants, heat
shock protein, anti-apoptosis agents, metabolic agents,
nuclear factor kappa B inducers, and traditional Chinese
medicine have been used for the treatment of hepatic IRI
[19]. However, of these pharmacological agents, none
has become a routine component in clinical practice and
further studies are needed in this area.
ABS is a medical plant extract containing Glycyrrhiza
glabra, Urtica dioica, Alpinia officinarum, Thymus
vulgaris, and Vitis vinifera [11]. ABS is made use of
in clinical hemorrhages when bleeding cannot be
controlled by conventional methods [20, 21]. ABS has
been suggested as an alternative treatment method for
different types of bleeding that are refractory to treatment
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Table 3. Liver function parameters of groups.

Groups

ALT (U/L)
(mean ± SD)

Group 1(Sham)

66.5 ± 11.36 x y

Group 2(IRI)

271.40 ± 85.9

xz

Group 3(IRI+ABS)

139.1 ± 31.75

yz

Albumine
(g/dL)
(mean ± SD)

T Bilirubin
(mg/dL)
(mean ± SD)

D Bilirubin
(mg/dL)
(mean ± SD)

176.6 ± 29.44 x y

3.80 ± 0.15 x p

0.06 ± 0.01

0.03 ± 0.01

566.10 ± 66.88

xt

3.20 ± 0.22

xu

0.04 ± 0.01

0.02 ± 0.00

322.80 ± 60.65

yt

3.52 ± 0.12

pu

0.07 ± 0.01

0.03 ± 0.01

AST (U/L)
(mean ± SD)

Significantly different. xP < 0.001 for group 1 versus group 2, yP < 0.001 for group 1 versus group 3, zP = 0.002 for group 2 and group 3,
t
P < 0.001 for group 2 and group 3, pP = 0.001 for group 1 versus group 3, uP = 0.005 for group 2 versus group 3.
AST: Aminotransferase, ALT: Alanine aminotransferase, SD: Standard deviation, T: Total, D: Direct.
Table 4. Oxidative stress parameters of the groups.

Groups

TAS
(mean ± SD)
(µmol/g protein)

TOS
(mean ± SD)
(µmol/g protein)

MDA
(mean ± SD)
(nmol/g protein)

FOP
(mean ± SD)
(FP/g protein)

Group 1(Sham)

204.43 ± 13.27 x y

17.6 ± 3.99 x

9.17 ± 3.12 x p

6.23 ± 1.4 x p

Group 2(IRI)

130.82 ± 20.41 xz

33.44 ± 8.36 x t

26.64 ± 6.07 x z

16.76 ± 2.52 x u

Group 3(IRI+ABS)

174.45 ± 21.14

20.55 ± 3.13

15.5 ± 3.5

10.34 ± 2.23 p u

yz

t

pz

Significantly different, xP < 0.001 for group 1 versus group 2, yP = 0.005 for group 1 versus group 3, zP = 0.001 for
group 2 and group 3, tP = 0.002 for group 2 and group 3, pP = 0.001 for group 1 versus group 3, uP = 0.005 for
group 2 versus group 3, x u P < 0.001 for group 2 versus group 3.
TAS: Total antioxidant status, TOS: Total oxidant status, MDA: Malondialdehyde, FOP: Fluorescent oxidant
products.

with conventional procedures. ABS has also been shown
to have efficient antiinfective, antineoplastic, and
curative modulator properties. The current perspective
for the use of ABS is to provide hemostasis and promote
wound healing [22]. In addition to hemostatic effects,
ABS also has antioxidant and antiinflammatory effects
due to the integral components. For example, Thymus
vulgaris shows an antioxidant effect with inhibition of
lipid peroxidation and T reactive substance, thereby
increasing antioxidant enzyme activity, and total
antioxidant status. It also has an antiinflammatory effect
due to inhibition of edema, leukocyte migration, and
lipopolysaccharide-stimulated inflammation [23–26].
Glycyrrhiza glabra demonstrates antiinflammatory
effects through inhibition of reactive oxygen species,
decreasing lipopolysaccharide inflammatory mediators
and providing protection against lipid peroxidation
of liposomal membrane and antioxidant effect, as the
low density lipoprotein is protected against oxidation
[27]. Vitis vinifera increases antioxidant capacity by
protecting against low density lipoprotein oxidation,
and scavenging free radicals [28]. Alpinia officinarum
exhibits antiinflammatory and antioxidant activity by
binding into the active sides of cyclooxygenase 2 (COX

2) and behaving as COX 2 inhibitors [29]. Urtica dioica
shows a greater antioxidant potential with reactive oxygen
species scavenging capacity [30]. With the antioxidant
and antiinflammatory effects of all these components,
ABS can show a hepatoprotective effect on liver IRI, as
was demonstrated in this study.
Hasgul et al. showed the antioxidant effects of ABS
on aspirin-related oxidative mucosal damage in a rat
model of gastric injury [31], and the antiinflammatory
effects of ABS were shown by Koçak et al. in experimental
colitis [13]. However, to the best of our knowledge, this
study is the first to have investigated the antioxidant and
hepatoprotective effects of ABS in an experimental model
of liver IRI. The results demonstrated that the IRI + ABS
group had higher levels of albumin and lower levels of
AST and ALT than the IRI group. Furthermore, the IRI
+ ABS group had lower levels of TOS, FOP and MDA,
and higher levels of TAS than the IRI group. According to
the histopathological results, the congestion scores were
found to be statistically decreased in the IRI + ABS group
compared to the IRI group. Although vacuolization and
necrosis were seen to be higher within the IRI group
compared to the IRI + ABS group, the difference was not
statistically significant. This could have been the result
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of the limited sample sizes of the groups or the relatively
shorter time for experimental reperfusion injury to occur
than for necrosis and vacuolization.
In conclusion, ABS has a strong hepatoprotective effect
due to its antiinflammatory and antioxidant properties.
Therefore, it may be suggested that ABS could be used as a
potential therapeutic agent for IRI.
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